![Seng Chin Mah](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Seng Chin Mah
Sociétés | Poste | Début | Fin |
---|---|---|---|
BioVersys AG
![]() BioVersys AG Miscellaneous Commercial ServicesCommercial Services BioVersys AG operates as a holding company, which specializes in the research and development of small molecules acting on novel bacterial targets. Its research focuses on nosocomial infection and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland. | Président | - | - |
Historique de carrière de Seng Chin Mah
Anciens postes connus de Seng Chin Mah
Sociétés | Poste | Début | Fin |
---|---|---|---|
Canyon Pharmaceuticals, Inc.
![]() Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Directeur Général | - | - |
Président | 03/08/2009 | - |
Statistiques
Internationale
Etats-Unis | 2 |
Suisse | 2 |
Opérationnelle
Chairman | 2 |
Chief Executive Officer | 1 |
Sectorielle
Health Technology | 2 |
Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Canyon Pharmaceuticals, Inc.
![]() Canyon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Canyon Pharmaceuticals, Inc. develops and manufactures pharmaceutical products. Its products include Revasc and Iprivask. The firm produces products to treat various immunity diseases. The company is headquartered in Hunt Valley, MD. | Health Technology |
BioVersys AG
![]() BioVersys AG Miscellaneous Commercial ServicesCommercial Services BioVersys AG operates as a holding company, which specializes in the research and development of small molecules acting on novel bacterial targets. Its research focuses on nosocomial infection and tuberculosis. The company was founded by Marc Gitzinger and Marcel Tigges on September 24, 2008 and is headquartered in Basel, Switzerland. | Commercial Services |
- Bourse
- Insiders
- Seng Chin Mah
- Expérience